The role of current surgical therapy for pediatric/adolescent and adult patients with bronchiectasis

Ulutaş, Hakkı

doi:10.5606/tgkdc.dergisi.2017.12775

Cited by 1 publication

(1 citation statement)

References 35 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In previous studies, complete recovery rates of symptoms after surgical treatment of bronchiectasis were reported as 82.1% in children and 88.7% in adults. [9] In this study, the rate of disappearance of symptoms, suggestive of complete recovery, was found to be 72.2%, consistent with the literature. The most important factor affecting the complete disappearance of symptoms after surgical treatment is that whether the resection is anatomic or not.…”

Section: Discussionsupporting

confidence: 91%

Anxiety and depression as possible criteria in the treatment of bronchiectasis

Keskin¹,

Dirol²,

Ergin³

2021

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

Background: The aim of this study was to investigate the effect of bronchiectasis operation on anxiety and depression. Methods: Between August 2014 and March 2019, a total of 167 patients with bronchiectasis (107 males, 60 females; mean age: 43.5±13.9 years; range, 18 to 84 years) who received medical (n=70) and surgical (n=97) treatment were retrospectively analyzed. Data including patients" characteristics, operation indication, operation type, and bronchiectasis localization were obtained from the electronic patient files. The patients were reached via phone calls and evaluated whether the operation provided a significant symptomatic improvement and whether the symptoms disappeared. The number of exacerbations/hospitalizations associated with bronchiectasis within the last year was also questioned. The anxiety and depression status of the patients in both groups was assessed by the Hospital Anxiety and Depression Scale. Results: Eleven (15%) patients in the medical group and 10 (10%) patients in the surgical group had an anxiety score above 7. Twenty-one (30%) patients in the medical group and 10 (10%) patients in the surgical group had a depression score above 7. Both the anxiety and depression scores were significantly lower in the surgical group than the medical group (p<0.001). Annual exacerbation and annual hospitalization rates were also significantly lower in the surgical group (p<0.001). Conclusion: Our study results suggest that patients with bronchiectasis treated medically rather than surgically are more prone to be anxious and depressive. The benefits of surgical treatment in patients with bronchiectasis is not limited to improving symptoms and decreasing the frequency of exacerbations/hospitalizations. We believe that surgical treatment also reduces anxiety and depression and improve the quality of life. While making a surgical decision, the anxiety/depression status of bronchiectasis patients should be considered.

show abstract

Section: Discussionsupporting

confidence: 91%